April 7, 2020 10:11am
Jumps +$0.85 or +24.7% to $4.27
PSTI plans to apply for initiation of multinational clinical trial for treatment of complications associated with COVID-19
PSTI preliminary data from its compassionate use program, treated seven patients suffering from acute respiratory failure and inflammatory complications associated with COVID-19 with PSTI’s PLX cells, in three medical centers in Israel.
- All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS)